Acetylsalicylic acid Recruiting Phase N/A Trials for Hepatocellular,Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02748304Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma